Market Place
Sourcing Support
CinCor Announces Receipt of Minutes with FDA on Planned PIII of Baxdrostat
21 Feb 2023 //
GLOBENEWSWIRE
AstraZeneca to acquire CinCor Pharma in nearly $2 billion deal
10 Jan 2023 //
PRESS RELEASE
CinCor`s hypertension drug loses halo after phase 2 fail
29 Nov 2022 //
FIERCEBIOTECH
CinCor Pharma Announces Publication in the NEM of Phase 2 BrigHtn Data
07 Nov 2022 //
GLOBENEWSWIRE
CinCor Pharma Announces Presentation of Phase 1 Clinical Data for Baxdrostat
25 Oct 2022 //
GLOBENEWSWIRE
CinCor Pharma Announces Oral Presentation of Phase 1 Data for Baxdrostat
12 Oct 2022 //
CINCOR
CinCor Announces Presentation of Phase 1 Clinical Data for Baxdrostat
22 Aug 2022 //
GLOBENEWSWIRE
CinCor raises $225M on back of positive PhII readout
11 Aug 2022 //
ENDPOINTS NEWS
CinCor Pharma Announces Last Patient Randomized in Phase 2 HALO Trial
26 Jul 2022 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.